Julian S Rechberger

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 24

Top Topics

Finite Element Analysis

Total Hip Arthroplasty

Top Venues

Expert opinion on therapeutic targets

Journal of clinical medicine

NPJ precision oncology

Therapeutic delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Leo F Nonnenbroich, Samantha M Bouchal, Elena Millesi, Julian S Rechberger, Soumen Khatua, David J Daniels
H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions. Cells 13 (13) (2024)
Erica A Power, Elena Millesi, Julian S Rechberger, David J Daniels
CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand? Immunotherapy (2024)
Leo F Nonnenbroich, Samantha M Bouchal, Elena Millesi, Julian S Rechberger, Soumen Khatua, David J Daniels
H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions. Cells 13 (13) (2024)
Julian S Rechberger, Blake T Power, Erica A Power, Cody L Nesvick, David J Daniels
H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics. Expert opinion on therapeutic targets 27 (1) (2023)
Wouter J F Vanbilloen, Julian S Rechberger, Jacob B Anderson, Leo F Nonnenbroich, Liang Zhang, David J Daniels
Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood-Brain Barrier to Treat Brain Tumors. Pharmaceutics 15 (7) (2023)
Jawad Fares, Zachary B Davis, Julian S Rechberger, Stephanie A Toll, Jonathan D Schwartz, David J Daniels, Jeffrey S Miller, Soumen Khatua
Advances in NK cell therapy for brain tumors. NPJ precision oncology 7 (1) (2023)
Julian S Rechberger, Stephanie A Toll, Wouter J F Vanbilloen, David J Daniels, Soumen Khatua
Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment. Diagnostics (Basel, Switzerland) 13 (14) (2023)
Jawad Fares, Zachary B Davis, Julian S Rechberger, Stephanie A Toll, Jonathan D Schwartz, David J Daniels, Jeffrey S Miller, Soumen Khatua
Advances in NK cell therapy for brain tumors. NPJ precision oncology 7 (1) (2023)
Erica A Power, Julian S Rechberger, Liang Zhang, Ju-Hee Oh, Jacob B Anderson, Cody L Nesvick, Jizhi Ge, Edward H Hinchcliffe, William F Elmquist, David J Daniels
Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time. Neuro-oncology advances 5 (1) (2023)
Jawad Fares, Zachary B Davis, Julian S Rechberger, Stephanie A Toll, Jonathan D Schwartz, David J Daniels, Jeffrey S Miller, Soumen Khatua
Advances in NK cell therapy for brain tumors. NPJ precision oncology 7 (1) (2023)
Erica A Power, Julian S Rechberger, Liang Zhang, Ju-Hee Oh, Jacob B Anderson, Cody L Nesvick, Jizhi Ge, Edward H Hinchcliffe, William F Elmquist, David J Daniels
Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time. Neuro-oncology advances 5 (1) (2023)
Julian S Rechberger, Blake T Power, Erica A Power, Cody L Nesvick, David J Daniels
H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics. Expert opinion on therapeutic targets (2023)
Karolina I Pellot Ortiz, Julian S Rechberger, Leo F Nonnenbroich, David J Daniels, Jann N Sarkaria
MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation. Biomedicines 11 (7) (2023)
Elena Millesi, Julian S Rechberger, Huan Wang, Samir Mardini, Robert J Spinner, David J Daniels
Advancements in therapeutic approaches for malignant peripheral nerve sheath tumor. Therapeutic delivery (2023)
Gabriel Illmeier, Julian S Rechberger
The Limitations of Anterior Knee Displacement during Different Barbell Squat Techniques: A Comprehensive Review. Journal of clinical medicine 12 (8) (2023)
Julian S Rechberger, Blake T Power, Erica A Power, Cody L Nesvick, David J Daniels
H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics. Expert opinion on therapeutic targets 27 (1) (2023)
Julian S Rechberger, Blake T Power, Erica A Power, Cody L Nesvick, David J Daniels
H3K27-altered diffuse midline glioma: A paradigm shifting opportunity in direct delivery of targeted therapeutics. Expert opinion on therapeutic targets (2023)
Julian S Rechberger, Blake T Power, Erica A Power, Cody L Nesvick, David J Daniels
H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics. Expert opinion on therapeutic targets 27 (1) (2023)
Gabriel Illmeier, Julian S Rechberger
The Limitations of Anterior Knee Displacement during Different Barbell Squat Techniques: A Comprehensive Review. Journal of clinical medicine 12 (8) (2023)
Gabriel Illmeier, Julian S Rechberger
The Limitations of Anterior Knee Displacement during Different Barbell Squat Techniques: A Comprehensive Review. Journal of clinical medicine 12 (8) (2023)
Gabriel Illmeier, Julian S Rechberger
The Limitations of Anterior Knee Displacement during Different Barbell Squat Techniques: A Comprehensive Review. Journal of clinical medicine 12 (8) (2023)
Julian S Rechberger, David J Daniels
Locoregional infusion of IL13Rα2-specific immunotoxins in children and adults with high-grade glioma. Therapeutic delivery 13 (8) (2022)
Julian S Rechberger, Kendra A Porath, Liang Zhang, Cody L Nesvick, Randy S Schrecengost, Jann N Sarkaria, David J Daniels
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma. Pharmaceutics 14 (5) (2022)
Julian S Rechberger, Cody L Nesvick, David J Daniels
Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets. Expert opinion on therapeutic targets 26 (3) (2022)